Close Menu

NEW YORK (GenomeWeb) – DNA Script announced today that it has acquired an exclusive license from Dynamic Combinatorial Chemistry (DCC) to a novel DNA building block for use in enzymatic DNA synthesis.

The building blocks, which were initially developed by DCC affiliate Firebird Biomolecular Sciences, are reversible terminator nucleotides with cleavable protective groups that help in controlling the enzymatic synthesis process, according to DNA Script COO Sylvain Gariel.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.